©The Author(s) 2022.
World J Clin Cases. Apr 26, 2022; 10(12): 3739-3753
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3739
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3739
Table 2 Data of secondary surgery for platinum-resistant recurrent epithelial ovarian carcinoma
| Characteristic | Patients (n = 38) |
| Preoperative ECOG score, n (%) | |
| 0-1 | 33 (86.8) |
| 2 | 5 (13.2) |
| Location of recurrent lesions, n (%) | |
| Pelvic cavity | 7 (18.4) |
| Abdominopelvic cavity | 16 (42.1) |
| Pelvic/abdominal cavity + retroperitoneal | 15 (39.5) |
| Residual lesions of the secondary surgery, n (%) | |
| R0 | 25 (65.8) |
| R1-R2 | 13 (34.2) |
| Intraoperative organ resection, n (%) | |
| No | 13 (34.2) |
| Yes | 25 (65.8) |
| Bleeding amount (mL), n (%) | |
| ≤ 400 | 20 (52.6) |
| 401-800 | 12 (31.6) |
| > 801 | 6 (15.8) |
| Perioperative complications, n (%) | |
| No | 29 (76.3) |
| Yes | 9 (23.7) |
| Postoperative chemotherapy, n (%) | |
| No | 2 (5.3) |
| Yes | 36 (94.7) |
| Postoperative use of targeted drugs, n (%) | |
| No | 33 (86.8) |
| Yes | 5 (13.2) |
| Postoperative hospital stay, n (%) | |
| ≤ 10 d | 24 (63.2) |
| 11-20 d | 12 (31.6) |
| > 20 d | 2 (5.2) |
- Citation: Zhao LQ, Gao W, Zhang P, Zhang YL, Fang CY, Shou HF. Surgery in platinum-resistant recurrent epithelial ovarian carcinoma. World J Clin Cases 2022; 10(12): 3739-3753
- URL: https://www.wjgnet.com/2307-8960/full/v10/i12/3739.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i12.3739